FICC-Seq: a method for enzyme-specified profiling of methyl-5-uridine in cellular RNA.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
04 11 2019
Historique:
accepted: 17 07 2019
revised: 03 07 2019
received: 20 03 2019
pubmed: 31 7 2019
medline: 18 12 2019
entrez: 31 7 2019
Statut: ppublish

Résumé

Methyl-5-uridine (m5U) is one the most abundant non-canonical bases present in cellular RNA, and in yeast is found at position U54 of tRNAs where modification is catalysed by the methyltransferase Trm2. Although the mammalian enzymes that catalyse m5U formation are yet to be identified via experimental evidence, based on sequence homology to Trm2, two candidates currently exist, TRMT2A and TRMT2B. Here we developed a genome-wide single-nucleotide resolution mapping method, Fluorouracil-Induced-Catalytic-Crosslinking-Sequencing (FICC-Seq), in order to identify the relevant enzymatic targets. We demonstrate that TRMT2A is responsible for the majority of m5U present in human RNA, and that it commonly targets U54 of cytosolic tRNAs. By comparison to current methods, we show that FICC-Seq is a particularly robust method for accurate and reliable detection of relevant enzymatic target sites. Our associated finding of extensive irreversible TRMT2A-tRNA crosslinking in vivo following 5-Fluorouracil exposure is also intriguing, as it suggests a tangible mechanism for a previously suspected RNA-dependent route of Fluorouracil-mediated cytotoxicity.

Identifiants

pubmed: 31361898
pii: 5541094
doi: 10.1093/nar/gkz658
pmc: PMC6821191
doi:

Substances chimiques

Saccharomyces cerevisiae Proteins 0
RNA 63231-63-0
RNA, Transfer 9014-25-9
tRNA Methyltransferases EC 2.1.1.-
Deoxyribonucleases EC 3.1.-
TRM2 protein, S cerevisiae EC 3.1.-
Fluorouracil U3P01618RT
Uridine WHI7HQ7H85

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e113

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/N000749/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Proc Natl Acad Sci U S A. 2008 May 13;105(19):6876-81
pubmed: 18451029
Biochemistry. 1991 Oct 8;30(40):9724-8
pubmed: 1911760
Nat Biotechnol. 2013 May;31(5):458-64
pubmed: 23604283
Biomacromolecules. 2006 Dec;7(12):3321-6
pubmed: 17154459
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Biochemistry. 1998 Jan 6;37(1):344-51
pubmed: 9425056
Nucleic Acids Res. 2019 Mar 18;47(5):2143-2159
pubmed: 30698754
Cell Rep. 2016 May 24;15(8):1837-47
pubmed: 27184847
Mol Biol Cell. 2007 Mar;18(3):1107-17
pubmed: 17215513
RNA. 2000 Oct;6(10):1356-79
pubmed: 11073213
BMC Cancer. 2010 Mar 22;10:108
pubmed: 20307320
Cell. 2005 Mar 11;120(5):599-611
pubmed: 15766524
Cell Rep. 2013 Jul 25;4(2):255-61
pubmed: 23871666
Biochimie. 1994;76(12):1133-42
pubmed: 7748948
Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14270-5
pubmed: 10588695
Methods. 2019 Mar 1;156:60-65
pubmed: 30308313
J Biol Chem. 2000 Feb 11;275(6):4251-7
pubmed: 10660592
Nucleic Acids Res. 2014 Oct;42(18):e142
pubmed: 25129236
Nucleic Acids Res. 2014 Jun;42(11):7346-57
pubmed: 24831542
Biochem Biophys Res Commun. 2019 Jan 8;508(2):410-415
pubmed: 30502085
RNA. 2004 Feb;10(2):192-9
pubmed: 14730018
Nucleic Acids Res. 2018 Jan 4;46(D1):D303-D307
pubmed: 29106616
J Bacteriol. 1980 Jan;141(1):67-73
pubmed: 6153386
Mol Pharmacol. 1982 Mar;21(2):468-73
pubmed: 7099147
Biochem Pharmacol. 1984 Mar 1;33(5):745-50
pubmed: 6201174
PLoS Biol. 2010 Oct 26;8(10):e1000530
pubmed: 21048981
RNA. 2000 Jun;6(6):844-60
pubmed: 10864043
Nucleic Acids Res. 2015 Nov 16;43(20):9950-64
pubmed: 26365242
J Am Chem Soc. 2018 Jun 13;140(23):7135-7143
pubmed: 29782154
J Biol Chem. 2006 Dec 22;281(51):38969-73
pubmed: 17085441
Nat Methods. 2016 Dec 29;14(1):23-31
pubmed: 28032622
Genome Biol. 2012 Aug 03;13(8):R67
pubmed: 22863408
Nat Rev Cancer. 2003 May;3(5):330-8
pubmed: 12724731
J Biol Chem. 2002 Jun 21;277(25):22240-50
pubmed: 11919191
Biochemistry. 1992 Oct 27;31(42):10295-302
pubmed: 1420148
J Biol Chem. 1981 Oct 10;256(19):9802-5
pubmed: 7275977
Biochem J. 1997 Jul 1;325 ( Pt 1):277-86
pubmed: 9224656
Nucleic Acids Res. 2016 Jan 4;44(D1):D184-9
pubmed: 26673694
PLoS One. 2013 Nov 01;8(11):e78172
pubmed: 24223771
Biochemistry. 1987 Dec 29;26(26):8599-606
pubmed: 3327525
Nat Struct Mol Biol. 2010 Jul;17(7):909-15
pubmed: 20601959
Nucleic Acids Res. 2018 Oct 12;46(18):9764-9775
pubmed: 30102387

Auteurs

Jean-Michel Carter (JM)

Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK.

Warren Emmett (W)

The Francis-Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
University College London Genetics Institute, Gower Street, London, WC1E 6BT, UK.

Igor Rdl Mozos (IR)

The Francis-Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Department for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.

Annika Kotter (A)

Johannes Gutenberg-Universität, Institut für Pharmazie und Biochemie, Staudinger Weg 5, 55128 Mainz, Germany.

Mark Helm (M)

Johannes Gutenberg-Universität, Institut für Pharmazie und Biochemie, Staudinger Weg 5, 55128 Mainz, Germany.

Jernej Ule (J)

The Francis-Crick Institute, 1 Midland Road, London, NW1 1AT, UK.
Department for Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.

Shobbir Hussain (S)

Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath, BA2 7AY, UK.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH